Spire Wealth Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,000
| Closed | -$11K | – | 2875 |
|
|
2022
Q1 | $11K | Sell |
8,000
-245,723
| -97% | -$338K | ﹤0.01% | 2018 |
|
|
2021
Q4 | $662K | Buy |
+253,723
| New | +$662K | 0.01% | 602 |
|
|
2021
Q2 | – | Sell |
-289,024
| Closed | -$985K | – | 3078 |
|
|
2021
Q1 | $985K | Buy |
+289,024
| New | +$985K | 0.03% | 446 |
|